Stocks · Health care · Biological Products, (No Diagnostic Substances)

Artiva Biotherapeutics, Inc.

ARTV Clue Score30

United States Fiscal year ends December CIK 0001817241 Results filed 27 Oct 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Fred Aslan

2 Nov 2026

Chief Executive Officer

Sell

62,178

$4.18

$259.97K

Subhashis Banerjee

2 Nov 2026

Chief Medical Officer

Sell

1,110

$4.18

$4.64K

Jennifer Bush

2 Nov 2026

COO, CLO, Compliance Officer

Sell

8,439

$4.18

$35.28K

Christopher Horan

2 Nov 2026

Chief Tech Operations Officer

Sell

10,423

$4.18

$43.58K

Show all 4 transactions →

What was left out

Form 4 filings counted 5

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 4

Transactions with no price 0

Shares from compensation/vesting 0

History held since 22 Jul 2024